ATAD1 and malaria: This study successfully evaluated the associations between antibody responses against GLURP R2, MSP1 block 2 hybrid and the peptide AS202.11 and the risk of malaria in two populations (Burkina Faso and Ghana) with different malaria transmission intensities.